Write in a clean editor, then format for Neuroscience Applied in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Neuroscience Applied is a peer-reviewed journal published by Elsevier, covering Schizophrenia research and treatment, Treatment of Major Depression, Tryptophan and brain disorders.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Neuroscience Applied 12 (2023) 45–58.
Formats any DOI in Neuroscience Applied style. No sign-up. |
| Publishes research in | Schizophrenia research and treatment Treatment of Major Depression Tryptophan and brain disorders Bipolar Disorder and Treatment Stress Responses and Cortisol |
| ISSN | 2772-4085 |
| Citation impact (2-yr) | 0.2 |
| h-index | 15 |
| i10-index | 28 |
| Total citations | 1,224 |
| Article processing charge | $2,000 |
| Open access | Yes |
| Top institutions publishing here | Centro de Investigación Biomédica en Red de Salud Mental |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Psychedelics such as psilocybin have recently gained remarkable interest in both the specialist literature and the lay press because studies suggest that these substances may have great therapeutic potential in various psychiatric disorders, including major depression. However, clinical trials with psychedelic drugs pose particular methodological challenges to researchers, some of which differ considerably from those…
The number of individuals suffering from neuropsychiatric disorders (NPDs) has increased worldwide, with 3 million disability-adjusted life-years calculated in 2019. Though research using various approaches including genetics, imaging, clinical and animal models has advanced our knowledge regarding NPDs, we still lack basic knowledge regarding the underlying pathophysiological mechanisms. Moreover, there is an urgent need for…
Stress, encompassing psychological, physical, and physiological challenges, is an important factor affecting an individual's well-being and potentially leading to psychiatric, neurodegenerative, immune, and metabolic disorders. However, not everyone exposed to stress develops these conditions, highlighting the concept of resilience. Resilience is a dynamic process categorized into four dimensions: pre-existing resilience capacity, ongoing resilience processes, post-stress…
Semaglutide, a glucagon-like peptide-1 receptor agonist, is an effective drug reducing body weight and decreasing motivation for palatable food. The mechanisms underlying its effects on food reward remain unclear. We aimed to determine the impact of semaglutide on food reward collection and dopamine-neuron activity in the ventral tegmental area (VTA) upon exposure to a cue-induced…
Virtual Reality (VR) has emerged as a promising tool in the treatment of anxiety disorders, particularly for exposure-based interventions. This literature review summarizes recent research on the efficacy of Virtual Reality Exposure Therapy (VRET) for addressing public speaking anxiety (PSA) and Social Anxiety Disorder (SAD). VRET demonstrates comparable efficacy to traditional in vivo exposure. While…
